UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (LOSS) - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Total revenue	$ 424.0	$ 461.4
Total cost of revenue	231.7	246.7
Gross profit	192.3	214.7
Operating expenses:
Selling, general and administrative	121.2	120.1
Research and development	48.5	46.4
Other charges, net	6.2	6.3
Total operating expenses	175.9	172.8
Operating income	16.4	41.9
Interest and other income (expense), net	(2.9)	(3.5)
Income before income taxes and noncontrolling interest in consolidated subsidiaries	13.5	38.4
Income tax provision	2.9	7.7
Consolidated net income	10.6	30.7
Net income attributable to noncontrolling interests in consolidated subsidiaries	0.1	(0.1)
Net income attributable to Bruker Corporation	$ 10.5	$ 30.8
Net income per common share attributable to Bruker Corporation shareholders:
Basic (in dollars per share)	$ 0.07	$ 0.20
Diluted (in dollars per share)	$ 0.07	$ 0.20
Weighted average common shares outstanding:
Basic (in shares)	154.2	156.7
Diluted (in shares)	155.4	157.9
Comprehensive income (loss)	$ 12.1	$ 17.0
Less: Comprehensive income (loss) attributable to noncontrolling interests	(0.1)	(0.1)
Less: Comprehensive income (loss) attributable to redeemable noncontrolling interest	(0.5)
Comprehensive income (loss) attributable to Bruker Corporation	12.7	17.1
Product
Total revenue	345.0	383.0
Total cost of revenue	180.5	197.5
Service
Total revenue	78.2	77.4
Total cost of revenue	51.1	49.1
Other
Total revenue	0.8	1.0
Total cost of revenue	$ 0.1	$ 0.1